GLP1R and type 2 diabetes mellitus: The peptide GLP1R and glucagon receptor agonist ZP2495 improved contractility of the heart and inhibited cardiomyocyte apoptosis in diabetic mice db/db (type 2 diabetes) with CAO and reperfusion [102].